Handelsbanken Fonder’s PRA Health Sciences, Inc. PRAH Stock Holding History

Handelsbanken Fonder’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,030	Closed	-$1.82M	–	1709
2021 Q2	$1.82M	Sell	11,030 -2,000	-15%	-$334K	0.01%	659
2021 Q1	$2M	Hold	13,030	–	–	0.01%	607
2020 Q4	$1.63M	Hold	13,030	–	–	0.01%	651
2020 Q3	$1.32M	Hold	13,030	–	–	0.01%	640
2020 Q2	$1.27M	Buy	+13,030	New	+$1.21M	0.01%	622
2019 Q3	–	Sell	-2,800	Closed	-$278K	–	198
2019 Q2	$278K	Buy	+2,800	New	+$267K	0.01%	186

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Handelsbanken Fonder's PRAH Position: Q3 2021 in Review

Handelsbanken Fonder sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 11,030 shares — an estimated $1.82M sold.

Handelsbanken Fonder first reported a position in PRAH in Q2 2019 and held it in 6 quarters. The position peaked at $2M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Handelsbanken Fonder reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Handelsbanken Fonder sold 11,030 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.82M.
Handelsbanken Fonder first reported a position in PRA Health Sciences, Inc. in Q2 2019 and held it in 6 quarters.
Handelsbanken Fonder's PRA Health Sciences, Inc. position peaked at $2M in Q1 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Handelsbanken Fonder's 13F filing for Q3 2021, filed 10 Nov 2021.